Injectable • 5.30mg • 1 count
$450.00
Form
Injectable
Strength
5.30mg
Quantity
1100
Semaglutide Plus, combining Semaglutide with Levocarnitine, is a novel formulation designed to support the body's natural metabolic processes, enhancing glycemic control and energy metabolism in adults. This innovative combination leverages the glucose-lowering efficacy of Semaglutide, a synthetic glucagon-like peptide-1 receptor agonist, with the added benefits of Levocarnitine, known for its role in fatty acid transport and energy production. Aimed at optimizing metabolic health, Semaglutide Plus offers a multifaceted approach to managing wellness, focusing on improving glycemic outcomes and supporting cardiovascular health.
Benefits:
- Enhances glycemic control in conjunction with diet and exercise, contributing to better management of metabolic health.
- Supports improved energy metabolism through Levocarnitine, aiding in the effective utilization of fatty acids.
- Demonstrates a favorable impact on cardiovascular outcomes, aligning with the primary endpoint of non-inferiority for major adverse cardiac events (MACE) in clinical trials.
- Offers a potent glucose-lowering effect, with evidence suggesting superior efficacy among GLP-1 receptor agonists.
- Provides an alternative option for individuals seeking to manage their metabolic health with a focus on minimizing hypoglycemia and promoting weight management.
Sources:
- "Cardiovascular outcomes trials in type 2 diabetes: Where do we go from here? Reflections from a Diabetes Care Editors’ Expert Forum" - Diabetes Care. Link
- "Efficacy and Safety of Semaglutide Compared with Liraglutide and Exenatide for Type 2 Diabetes: A Systematic Review and Network Meta-analysis" - The Lancet Diabetes & Endocrinology. Link